Stock TBIO TELESIS BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Telesis Bio, Inc.

Equities

TBIO

US1920031010

Market Closed - Nasdaq
Other stock markets
 02:00:00 04/05/2024 am IST 		5-day change 1st Jan Change
0.33 USD -6.83% Intraday chart for Telesis Bio, Inc. +3.64% -17.29%
18/04 Telesis Bio, Inc. Announces Appointment of Eric Esser to the Board of Directors CI
18/04 Telesis Bio Inc. Announces Strategic Focus on Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform and BioXp mRNA Solutions CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Telesis Bio, Inc. Announces Appointment of Eric Esser to the Board of Directors
Telesis Bio Inc. Announces Strategic Focus on Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform and BioXp mRNA Solutions
Telesis Bio, Inc. Announces Chief Executive Officer Changes
Telesis Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Telesis Bio, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2023
Telesis Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Telesis Bio, Inc. Provides Earnings Guidance for 2023
Telesis Bio, Inc. Announces Default of 2022 Term Loan Agreement
Telesis Bio, Inc. Announces Board Changes
Telesis Bio Names William Kullback as CFO
Telesis Bio Downgraded by KeyBanc Over 'Tepid' Biopharma Spending, 'Significant Dilution'
Telesis Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Top Premarket Gainers
Telesis Bio, Inc. Appoints Paul Meister as Director
Telesis Bio Secures $28 Million Preferred Equity Financing
Telesis Bio Makes First Commercial Shipment of BioXp Select DNA Cloning Kit; Shares Rise
Telesis Bio Makes First Commercial Shipment of BioXp NGS Library Prep Kit
Wall Street Set to Open Higher; Import Prices Rebound More Than Expected
Telesis Bio Q1 Loss Narrows While Sales Increase
Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TBIO Stock
  4. News Telesis Bio, Inc.
  5. Other languages